17
Mar

Prevention and Prediction: Understanding How Lung Cancer Progresses

New Penn Medicine studies will be presented at upcoming Multidisciplinary Thoracic Cancers Symposium

PHILADELPHIA – Treating the brain with a preventative course of radiation may help Small Cell Lung Cancer (SCLC) patients – whose tumors often spread to their brain — live longer, according to a new study from researchers in the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania. A separate study revealed that the most commonly-targeted mutation of Non-Small Cell Lung Cancer (NSCLC) is most likely to result in progression at the primary site. Both projects will be presented this weekend at the 2017 Multidisciplinary Thoracic Cancers Symposium in San Francisco.

The first study (Oral Abstract Session, Presentation #11) deals with SCLC, which is a type of lung cancer with the strongest ties to smoking. It’s particularly aggressive, with between 60 and 70 percent of patients diagnosed at advanced stages of the disease. The disease will spread to the brain in more than half of the patients.

Read Full New Release Here >>